Detalhe da pesquisa
1.
[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
Eur J Nucl Med Mol Imaging
; 50(3): 892-907, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36334104
2.
Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 48(1): 123-133, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385647
3.
Cholecystokinin-2 receptor targeting by [68Ga]Ga-DOTA-MGS5 PET/CT in a patient with extensive disease small cell lung cancer.
Eur J Nucl Med Mol Imaging
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38740575
4.
68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.
Eur J Nucl Med Mol Imaging
; 44(6): 941-949, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28138747
5.
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
Eur J Nucl Med Mol Imaging
; 44(10): 1647-1655, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28589253
6.
Visualization of malignant infiltration of the thoracic duct on 68Ga PSMA-11 PET/CT in a prostate cancer patient with biochemical recurrence.
Eur J Nucl Med Mol Imaging
; 47(8): 2042-2043, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838582
7.
Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023.
Theranostics
; 14(3): 940-953, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38250038
8.
Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: Agonist, Antagonist and Alternatives.
Semin Nucl Med
; 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490913
9.
Small cell neuroendocrine prostate cancer with adenocarcinoma components-case report and literature review.
Transl Androl Urol
; 13(5): 868-878, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38855597
10.
Imaging Fibrosis.
PET Clin
; 18(3): 381-388, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990946
11.
Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the 68Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer.
J Nucl Med
; 64(6): 859-862, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657979
12.
Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study.
Eur Urol Oncol
; 2023 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37604763
13.
Enhancing Clinical Diagnosis for Patients With Persistent Pulmonary Abnormalities After COVID-19 Infection: The Potential Benefit of 68 Ga-FAPI PET/CT.
Clin Nucl Med
; 47(12): 1026-1029, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257062
14.
A Multi-Disciplinary Approach to Diagnosis and Treatment of Radionecrosis in Malignant Gliomas and Cerebral Metastases.
Cancers (Basel)
; 14(24)2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551750
15.
Incidental Finding of a Pancreatic Adenocarcinoma on [68Ga]Ga-PSMA-11 PET/CT in a mCRPC patient under [177Lu]Lu-PSMA-617 Radioligand Therapy.
Nuklearmedizin
; 63(3): 219-220, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190993
16.
High-resolution, hand-held camera for sentinel-node detection.
Cancer Biother Radiopharm
; 23(1): 43-52, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18298328
17.
Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer.
Cancer Biother Radiopharm
; 19(1): 81-4, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15068615